Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zbtb14
|
ENSMUSG00000049672.8 | zinc finger and BTB domain containing 14 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_69382433_69382798 | Zbtb14 | 435 | 0.747231 | 0.13 | 3.5e-01 | Click! |
chr17_69383719_69383948 | Zbtb14 | 7 | 0.857293 | 0.10 | 4.5e-01 | Click! |
chr17_69383185_69383694 | Zbtb14 | 120 | 0.903568 | 0.08 | 5.7e-01 | Click! |
chr17_69382802_69383119 | Zbtb14 | 90 | 0.944935 | 0.01 | 9.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_12650037_12651101 | 6.16 |
Gpr137b-ps |
G protein-coupled receptor 137B, pseudogene |
181 |
0.91 |
chr13_13393240_13394314 | 6.11 |
Gpr137b |
G protein-coupled receptor 137B |
153 |
0.93 |
chr1_132741692_132741971 | 4.01 |
Nfasc |
neurofascin |
34 |
0.98 |
chr15_84853296_84854003 | 3.72 |
Phf21b |
PHD finger protein 21B |
1461 |
0.35 |
chr18_36017856_36019112 | 3.72 |
Nrg2 |
neuregulin 2 |
13457 |
0.16 |
chr1_182763880_182764492 | 3.65 |
Susd4 |
sushi domain containing 4 |
174 |
0.95 |
chr13_49147195_49148263 | 3.59 |
Wnk2 |
WNK lysine deficient protein kinase 2 |
283 |
0.92 |
chr10_70599218_70599723 | 3.53 |
Phyhipl |
phytanoyl-CoA hydroxylase interacting protein-like |
179 |
0.96 |
chr13_9276296_9277300 | 3.48 |
Dip2c |
disco interacting protein 2 homolog C |
115 |
0.94 |
chr8_36457363_36458468 | 3.35 |
Trmt9b |
tRNA methyltransferase 9B |
267 |
0.92 |
chr6_114968557_114970098 | 3.31 |
Vgll4 |
vestigial like family member 4 |
147 |
0.97 |
chr15_78718711_78718919 | 3.30 |
Elfn2 |
leucine rich repeat and fibronectin type III, extracellular 2 |
44 |
0.97 |
chrX_6046872_6047632 | 3.29 |
Nudt11 |
nudix (nucleoside diphosphate linked moiety X)-type motif 11 |
201 |
0.92 |
chr8_121652380_121653356 | 3.22 |
Zcchc14 |
zinc finger, CCHC domain containing 14 |
33 |
0.95 |
chr13_54749516_54749829 | 2.96 |
Gprin1 |
G protein-regulated inducer of neurite outgrowth 1 |
3 |
0.96 |
chr3_86920207_86921011 | 2.93 |
Dclk2 |
doublecortin-like kinase 2 |
230 |
0.91 |
chr17_13759899_13761731 | 2.90 |
Afdn |
afadin, adherens junction formation factor |
141 |
0.73 |
chr2_168741597_168742465 | 2.83 |
Atp9a |
ATPase, class II, type 9A |
67 |
0.97 |
chr8_12915219_12915955 | 2.81 |
Gm15351 |
predicted gene 15351 |
32 |
0.8 |
chr4_149586082_149586582 | 2.80 |
Clstn1 |
calsyntenin 1 |
136 |
0.94 |
chr8_46210360_46210863 | 2.75 |
Slc25a4 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 |
419 |
0.73 |
chr6_103512188_103512529 | 2.75 |
Chl1 |
cell adhesion molecule L1-like |
1028 |
0.51 |
chr9_122571793_122572853 | 2.72 |
9530059O14Rik |
RIKEN cDNA 9530059O14 gene |
176 |
0.93 |
chr13_83744885_83745867 | 2.70 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
6513 |
0.13 |
chr6_122486412_122487163 | 2.66 |
Rimklb |
ribosomal modification protein rimK-like family member B |
282 |
0.86 |
chr5_30114426_30114725 | 2.66 |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
5730 |
0.12 |
chr6_113195212_113195613 | 2.65 |
Lhfpl4 |
lipoma HMGIC fusion partner-like protein 4 |
28 |
0.97 |
chr7_84409236_84410328 | 2.64 |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
101 |
0.96 |
chr1_89968155_89968712 | 2.62 |
Asb18 |
ankyrin repeat and SOCS box-containing 18 |
28019 |
0.16 |
chr19_47014440_47014752 | 2.60 |
Ina |
internexin neuronal intermediate filament protein, alpha |
102 |
0.87 |
chr9_120303463_120304028 | 2.60 |
Myrip |
myosin VIIA and Rab interacting protein |
191 |
0.93 |
chr19_47014756_47015333 | 2.57 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
109 |
0.77 |
chr1_3671269_3672324 | 2.54 |
Xkr4 |
X-linked Kx blood group related 4 |
298 |
0.89 |
chr1_23762182_23762730 | 2.51 |
B3gat2 |
beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S) |
445 |
0.89 |
chr10_29143551_29143727 | 2.50 |
Soga3 |
SOGA family member 3 |
200 |
0.8 |
chr15_74672233_74673425 | 2.49 |
Arc |
activity regulated cytoskeletal-associated protein |
259 |
0.85 |
chr1_178276084_178276584 | 2.47 |
4930527J03Rik |
RIKEN cDNA 4930527J03 gene |
305 |
0.84 |
chr2_25319011_25319403 | 2.45 |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
20 |
0.93 |
chr4_155694691_155694886 | 2.41 |
Fndc10 |
fibronectin type III domain containing 10 |
446 |
0.63 |
chr2_25290168_25290373 | 2.40 |
Lrrc26 |
leucine rich repeat containing 26 |
355 |
0.57 |
chr7_109010582_109011352 | 2.38 |
Tub |
tubby bipartite transcription factor |
142 |
0.95 |
chr3_33142428_33143483 | 2.35 |
Pex5l |
peroxisomal biogenesis factor 5-like |
121 |
0.97 |
chr15_73724296_73725739 | 2.31 |
Ptp4a3 |
protein tyrosine phosphatase 4a3 |
87 |
0.96 |
chr2_29965147_29966181 | 2.26 |
Sptan1 |
spectrin alpha, non-erythrocytic 1 |
13 |
0.96 |
chr1_109982419_109982761 | 2.25 |
Cdh7 |
cadherin 7, type 2 |
120 |
0.98 |
chr19_6497246_6497548 | 2.25 |
Nrxn2 |
neurexin II |
274 |
0.86 |
chr10_79613505_79614566 | 2.25 |
C2cd4c |
C2 calcium-dependent domain containing 4C |
10 |
0.95 |
chr18_61536259_61536665 | 2.23 |
Arhgef37 |
Rho guanine nucleotide exchange factor (GEF) 37 |
113 |
0.95 |
chr8_4216526_4217378 | 2.22 |
Prr36 |
proline rich 36 |
40 |
0.94 |
chr3_32616403_32617072 | 2.19 |
Gnb4 |
guanine nucleotide binding protein (G protein), beta 4 |
152 |
0.95 |
chr16_20240531_20241460 | 2.19 |
Gm49566 |
predicted gene, 49566 |
32 |
0.84 |
chr16_30308519_30309364 | 2.19 |
Gp5 |
glycoprotein 5 (platelet) |
1838 |
0.29 |
chr7_63212002_63212745 | 2.17 |
Chrna7 |
cholinergic receptor, nicotinic, alpha polypeptide 7 |
140 |
0.98 |
chr1_136259884_136260870 | 2.16 |
Gpr25 |
G protein-coupled receptor 25 |
496 |
0.56 |
chr11_74590019_74590518 | 2.15 |
Rap1gap2 |
RAP1 GTPase activating protein 2 |
82 |
0.97 |
chr13_56703202_56704180 | 2.14 |
Smad5 |
SMAD family member 5 |
23 |
0.98 |
chr1_54925534_54926512 | 2.14 |
Ankrd44 |
ankyrin repeat domain 44 |
331 |
0.88 |
chr3_88214175_88214875 | 2.13 |
Gm3764 |
predicted gene 3764 |
30 |
0.87 |
chr13_12105853_12107098 | 2.13 |
Ryr2 |
ryanodine receptor 2, cardiac |
16 |
0.98 |
chr18_37218144_37218452 | 2.10 |
Gm10544 |
predicted gene 10544 |
39776 |
0.08 |
chr2_28446566_28447382 | 2.09 |
Ppp1r26 |
protein phosphatase 1, regulatory subunit 26 |
108 |
0.95 |
chr4_151107641_151107996 | 2.07 |
Camta1 |
calmodulin binding transcription activator 1 |
485 |
0.8 |
chr15_75981276_75982456 | 2.07 |
Ccdc166 |
coiled-coil domain containing 166 |
576 |
0.51 |
chr2_131040943_131041967 | 2.07 |
Gfra4 |
glial cell line derived neurotrophic factor family receptor alpha 4 |
2 |
0.94 |
chr18_77564959_77566098 | 2.05 |
Rnf165 |
ring finger protein 165 |
367 |
0.89 |
chr6_31216476_31216989 | 2.05 |
Lncpint |
long non-protein coding RNA, Trp53 induced transcript |
366 |
0.84 |
chr4_59548682_59549911 | 2.04 |
Ptbp3 |
polypyrimidine tract binding protein 3 |
1 |
0.64 |
chr5_117414146_117414557 | 2.02 |
Ksr2 |
kinase suppressor of ras 2 |
351 |
0.83 |
chr13_24936983_24937836 | 2.02 |
9330162012Rik |
cDNA RIKEN 9330162012 gene |
8 |
0.77 |
chr9_36832333_36833401 | 2.01 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
59 |
0.97 |
chr14_18893044_18894412 | 2.00 |
Ube2e2 |
ubiquitin-conjugating enzyme E2E 2 |
10 |
0.98 |
chr11_97575281_97575640 | 1.99 |
Srcin1 |
SRC kinase signaling inhibitor 1 |
234 |
0.89 |
chr15_30172351_30173308 | 1.99 |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
138 |
0.98 |
chr7_44335486_44335667 | 1.98 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
440 |
0.6 |
chr4_42916856_42917426 | 1.97 |
Phf24 |
PHD finger protein 24 |
110 |
0.95 |
chr12_72236343_72236938 | 1.95 |
Rtn1 |
reticulon 1 |
46 |
0.98 |
chr10_60277532_60278257 | 1.95 |
Psap |
prosaposin |
266 |
0.92 |
chr4_17852942_17853620 | 1.95 |
Mmp16 |
matrix metallopeptidase 16 |
177 |
0.97 |
chr8_125569269_125570645 | 1.94 |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
149 |
0.97 |
chr4_126533465_126533667 | 1.94 |
Ago4 |
argonaute RISC catalytic subunit 4 |
94 |
0.94 |
chr3_31309752_31310443 | 1.93 |
Slc7a14 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 |
281 |
0.81 |
chr8_69881901_69882713 | 1.91 |
Cilp2 |
cartilage intermediate layer protein 2 |
5380 |
0.11 |
chr6_38662705_38663476 | 1.90 |
Clec2l |
C-type lectin domain family 2, member L |
23 |
0.98 |
chr11_6065246_6065453 | 1.87 |
Camk2b |
calcium/calmodulin-dependent protein kinase II, beta |
189 |
0.94 |
chr7_105580903_105581664 | 1.87 |
Apbb1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 |
5 |
0.95 |
chr4_57567702_57568390 | 1.87 |
Pakap |
paralemmin A kinase anchor protein |
113 |
0.98 |
chr9_56796197_56796384 | 1.86 |
Lingo1 |
leucine rich repeat and Ig domain containing 1 |
8 |
0.97 |
chr10_90828740_90829725 | 1.85 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
111 |
0.96 |
chr14_64589182_64589588 | 1.85 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
310 |
0.8 |
chr4_33189135_33189836 | 1.85 |
Pm20d2 |
peptidase M20 domain containing 2 |
52 |
0.97 |
chr6_119330585_119330869 | 1.83 |
Lrtm2 |
leucine-rich repeats and transmembrane domains 2 |
30 |
0.5 |
chr3_89319531_89319765 | 1.82 |
Efna3 |
ephrin A3 |
1983 |
0.12 |
chr14_70289350_70289831 | 1.82 |
Ppp3cc |
protein phosphatase 3, catalytic subunit, gamma isoform |
119 |
0.94 |
chr15_87543998_87544348 | 1.82 |
Tafa5 |
TAFA chemokine like family member 5 |
126 |
0.98 |
chr12_105336634_105337535 | 1.81 |
Tunar |
Tcl1 upstream neural differentiation associated RNA |
91 |
0.97 |
chr11_104232039_104232621 | 1.80 |
Mapt |
microtubule-associated protein tau |
746 |
0.59 |
chr2_143545715_143546271 | 1.79 |
Pcsk2os1 |
proprotein convertase subtilisin/kexin type 2, opposite strand 1 |
16 |
0.67 |
chr1_184999533_184999747 | 1.78 |
Mark1 |
MAP/microtubule affinity regulating kinase 1 |
70 |
0.98 |
chr9_22051033_22052180 | 1.77 |
Elavl3 |
ELAV like RNA binding protein 3 |
404 |
0.67 |
chr15_79804124_79804326 | 1.76 |
Nptxr |
neuronal pentraxin receptor |
484 |
0.67 |
chr17_35836572_35837313 | 1.76 |
Tubb5 |
tubulin, beta 5 class I |
118 |
0.89 |
chr5_33995599_33996957 | 1.75 |
Nat8l |
N-acetyltransferase 8-like |
294 |
0.82 |
chr3_123266883_123267457 | 1.75 |
Sec24d |
Sec24 related gene family, member D (S. cerevisiae) |
285 |
0.9 |
chr3_52102146_52103076 | 1.74 |
Maml3 |
mastermind like transcriptional coactivator 3 |
2465 |
0.23 |
chr10_13982761_13983386 | 1.74 |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
16049 |
0.19 |
chr4_42999870_43000376 | 1.73 |
Vcp |
valosin containing protein |
310 |
0.8 |
chr10_125388906_125389759 | 1.73 |
Slc16a7 |
solute carrier family 16 (monocarboxylic acid transporters), member 7 |
36 |
0.95 |
chr9_26733143_26733768 | 1.72 |
B3gat1 |
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
273 |
0.88 |
chr7_79536149_79536360 | 1.71 |
Gm35040 |
predicted gene, 35040 |
211 |
0.87 |
chr7_25305948_25306166 | 1.71 |
Tmem145 |
transmembrane protein 145 |
49 |
0.94 |
chr8_11727589_11727958 | 1.71 |
Arhgef7 |
Rho guanine nucleotide exchange factor (GEF7) |
52 |
0.95 |
chr4_45011783_45012858 | 1.70 |
Zbtb5 |
zinc finger and BTB domain containing 5 |
74 |
0.87 |
chr4_124894715_124894961 | 1.70 |
1700125G02Rik |
RIKEN cDNA 1700125G02 gene |
56 |
0.95 |
chr5_66745690_66746169 | 1.69 |
Limch1 |
LIM and calponin homology domains 1 |
40 |
0.97 |
chrX_64276892_64277123 | 1.68 |
Slitrk4 |
SLIT and NTRK-like family, member 4 |
11 |
0.99 |
chr9_15045344_15045748 | 1.68 |
Panx1 |
pannexin 1 |
68 |
0.97 |
chr1_16518910_16519418 | 1.68 |
Stau2 |
staufen double-stranded RNA binding protein 2 |
47 |
0.98 |
chr1_25829654_25830461 | 1.68 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
350 |
0.61 |
chr6_127768794_127769871 | 1.67 |
Prmt8 |
protein arginine N-methyltransferase 8 |
140 |
0.91 |
chr7_34132383_34133715 | 1.66 |
Wtip |
WT1-interacting protein |
219 |
0.88 |
chr9_70141410_70141836 | 1.66 |
Fam81a |
family with sequence similarity 81, member A |
45 |
0.97 |
chr1_54557548_54558278 | 1.66 |
Pgap1 |
post-GPI attachment to proteins 1 |
229 |
0.93 |
chr15_54571245_54571455 | 1.64 |
Mal2 |
mal, T cell differentiation protein 2 |
158 |
0.97 |
chr18_25754073_25754459 | 1.64 |
Celf4 |
CUGBP, Elav-like family member 4 |
109 |
0.97 |
chr14_70659174_70659883 | 1.63 |
Npm2 |
nucleophosmin/nucleoplasmin 2 |
284 |
0.85 |
chr13_39524261_39524439 | 1.63 |
Gm47351 |
predicted gene, 47351 |
8753 |
0.2 |
chr12_34907199_34907521 | 1.62 |
Hdac9 |
histone deacetylase 9 |
303 |
0.9 |
chr6_86028283_86028450 | 1.61 |
Add2 |
adducin 2 (beta) |
315 |
0.82 |
chr1_21078652_21079573 | 1.61 |
Tram2 |
translocating chain-associating membrane protein 2 |
117 |
0.93 |
chr1_9298798_9298958 | 1.60 |
Sntg1 |
syntrophin, gamma 1 |
14 |
0.98 |
chr4_56989694_56990486 | 1.60 |
Frrs1l |
ferric-chelate reductase 1 like |
46 |
0.98 |
chr4_119814771_119815180 | 1.60 |
Hivep3 |
human immunodeficiency virus type I enhancer binding protein 3 |
480 |
0.87 |
chr14_57525179_57526034 | 1.60 |
Il17d |
interleukin 17D |
829 |
0.55 |
chr5_38158989_38159808 | 1.58 |
Nsg1 |
neuron specific gene family member 1 |
7 |
0.97 |
chr5_139548548_139548699 | 1.58 |
Uncx |
UNC homeobox |
4725 |
0.19 |
chr3_107460175_107460519 | 1.58 |
Kcnc4 |
potassium voltage gated channel, Shaw-related subfamily, member 4 |
795 |
0.62 |
chr1_106713721_106715176 | 1.57 |
Bcl2 |
B cell leukemia/lymphoma 2 |
174 |
0.96 |
chr3_68572293_68572516 | 1.55 |
Schip1 |
schwannomin interacting protein 1 |
159 |
0.96 |
chr7_84151018_84152417 | 1.55 |
Abhd17c |
abhydrolase domain containing 17C |
47 |
0.87 |
chr18_60926924_60927473 | 1.55 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
249 |
0.89 |
chr17_25808842_25809037 | 1.55 |
Fbxl16 |
F-box and leucine-rich repeat protein 16 |
146 |
0.83 |
chr7_25179632_25179817 | 1.54 |
Pou2f2 |
POU domain, class 2, transcription factor 2 |
2 |
0.95 |
chr9_57940035_57940214 | 1.53 |
Sema7a |
sema domain, immunoglobulin domain (Ig), and GPI membrane anchor, (semaphorin) 7A |
11 |
0.97 |
chr7_67759134_67759665 | 1.53 |
Gm45102 |
predicted gene 45102 |
82 |
0.75 |
chr8_92460202_92460449 | 1.52 |
Gm45336 |
predicted gene 45336 |
5442 |
0.27 |
chr4_42172832_42172983 | 1.52 |
1700045I11Rik |
RIKEN cDNA 1700045I11 gene |
2062 |
0.15 |
chr8_70315603_70316677 | 1.52 |
Cers1 |
ceramide synthase 1 |
353 |
0.75 |
chr8_65617940_65618821 | 1.51 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
145 |
0.97 |
chr12_20614783_20615205 | 1.51 |
Gm48693 |
predicted gene, 48693 |
20 |
0.72 |
chr14_58075802_58076610 | 1.51 |
Fgf9 |
fibroblast growth factor 9 |
301 |
0.9 |
chr7_44336781_44337350 | 1.50 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
1049 |
0.26 |
chrX_59567756_59568348 | 1.50 |
Fgf13 |
fibroblast growth factor 13 |
4 |
0.99 |
chr10_13965362_13966015 | 1.48 |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
387 |
0.86 |
chr6_122485766_122486276 | 1.48 |
Rimklb |
ribosomal modification protein rimK-like family member B |
418 |
0.77 |
chr3_17790108_17790687 | 1.47 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
440 |
0.82 |
chr8_34397574_34397813 | 1.47 |
Gm33831 |
predicted gene, 33831 |
11865 |
0.16 |
chr9_86879639_86880662 | 1.47 |
Snap91 |
synaptosomal-associated protein 91 |
247 |
0.94 |
chr1_54194178_54194990 | 1.46 |
Hecw2 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 |
450 |
0.84 |
chr16_6348896_6349177 | 1.46 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
102 |
0.99 |
chr5_28464420_28464977 | 1.45 |
9530036O11Rik |
RIKEN cDNA 9530036O11Rik |
2286 |
0.28 |
chr9_122569026_122569238 | 1.45 |
9530059O14Rik |
RIKEN cDNA 9530059O14 gene |
3367 |
0.19 |
chr18_23310224_23310683 | 1.45 |
Gm7788 |
predicted gene 7788 |
93784 |
0.08 |
chr4_127987811_127988130 | 1.45 |
Csmd2 |
CUB and Sushi multiple domains 2 |
74 |
0.98 |
chr13_78203360_78204177 | 1.45 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
981 |
0.45 |
chr7_51622302_51622507 | 1.44 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
105 |
0.97 |
chr13_63431377_63432072 | 1.44 |
Fancc |
Fanconi anemia, complementation group C |
0 |
0.97 |
chr1_109982807_109983363 | 1.44 |
Cdh7 |
cadherin 7, type 2 |
79 |
0.99 |
chr14_58074986_58075750 | 1.44 |
Fgf9 |
fibroblast growth factor 9 |
253 |
0.92 |
chr10_43174435_43174840 | 1.44 |
9030612E09Rik |
RIKEN cDNA 9030612E09 gene |
62 |
0.55 |
chr1_42695585_42695788 | 1.43 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
82 |
0.89 |
chr8_84559305_84559515 | 1.43 |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
12316 |
0.17 |
chr2_4717789_4718511 | 1.43 |
Bend7 |
BEN domain containing 7 |
5 |
0.98 |
chrX_53642962_53643592 | 1.42 |
Rtl8a |
retrotransposon Gag like 8A |
405 |
0.74 |
chr17_87797115_87797327 | 1.41 |
Kcnk12 |
potassium channel, subfamily K, member 12 |
773 |
0.68 |
chrX_71962407_71962627 | 1.41 |
Prrg3 |
proline rich Gla (G-carboxyglutamic acid) 3 (transmembrane) |
107 |
0.96 |
chr1_9299450_9300170 | 1.40 |
Sntg1 |
syntrophin, gamma 1 |
68 |
0.97 |
chr5_65106807_65107827 | 1.40 |
Klhl5 |
kelch-like 5 |
222 |
0.92 |
chr18_61911105_61911686 | 1.37 |
Ablim3 |
actin binding LIM protein family, member 3 |
428 |
0.84 |
chr11_7213273_7214485 | 1.37 |
Igfbp3 |
insulin-like growth factor binding protein 3 |
18 |
0.98 |
chr14_34502394_34503413 | 1.37 |
Bmpr1a |
bone morphogenetic protein receptor, type 1A |
216 |
0.86 |
chr17_6490109_6490584 | 1.37 |
Tmem181b-ps |
transmembrane protein 181B, pseudogene |
23324 |
0.14 |
chr9_103111516_103112083 | 1.37 |
Rab6b |
RAB6B, member RAS oncogene family |
8 |
0.97 |
chr8_9158822_9158973 | 1.37 |
Gm44516 |
predicted gene 44516 |
1676 |
0.31 |
chr12_103324974_103325864 | 1.37 |
Asb2 |
ankyrin repeat and SOCS box-containing 2 |
10165 |
0.11 |
chr19_36553934_36555231 | 1.36 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
57 |
0.98 |
chr10_58812655_58813414 | 1.36 |
Gm9987 |
predicted gene 9987 |
108 |
0.77 |
chr3_25143947_25144344 | 1.36 |
Gm37136 |
predicted gene, 37136 |
77 |
0.55 |
chr7_45865731_45866731 | 1.35 |
Grin2d |
glutamate receptor, ionotropic, NMDA2D (epsilon 4) |
898 |
0.32 |
chr12_98574694_98574880 | 1.35 |
Kcnk10 |
potassium channel, subfamily K, member 10 |
75 |
0.96 |
chr17_24689861_24690203 | 1.35 |
Syngr3 |
synaptogyrin 3 |
77 |
0.9 |
chr18_61014126_61014291 | 1.35 |
Slc6a7 |
solute carrier family 6 (neurotransmitter transporter, L-proline), member 7 |
2 |
0.97 |
chr10_83337112_83337951 | 1.34 |
Slc41a2 |
solute carrier family 41, member 2 |
91 |
0.96 |
chr9_40346228_40346381 | 1.34 |
Gramd1b |
GRAM domain containing 1B |
14 |
0.96 |
chr9_83806172_83806700 | 1.33 |
Elovl4 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 |
159 |
0.96 |
chr2_146221890_146222279 | 1.33 |
Insm1 |
insulinoma-associated 1 |
163 |
0.95 |
chr10_86492150_86492313 | 1.33 |
Syn3 |
synapsin III |
334 |
0.82 |
chr7_4844524_4844964 | 1.32 |
Shisa7 |
shisa family member 7 |
48 |
0.94 |
chr9_4796094_4796268 | 1.32 |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
39 |
0.99 |
chr15_27680881_27682009 | 1.31 |
Otulinl |
OTU deubiquitinase with linear linkage specificity like |
67 |
0.97 |
chr6_88841841_88842983 | 1.31 |
Abtb1 |
ankyrin repeat and BTB (POZ) domain containing 1 |
428 |
0.42 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 5.2 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.1 | 3.3 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
1.1 | 1.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.9 | 5.7 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.9 | 3.7 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.9 | 3.5 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.8 | 2.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.8 | 3.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.8 | 2.4 | GO:0021586 | pons maturation(GO:0021586) |
0.8 | 2.4 | GO:0021564 | vagus nerve development(GO:0021564) |
0.8 | 2.4 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.7 | 2.2 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.7 | 1.4 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.7 | 2.9 | GO:0046959 | habituation(GO:0046959) |
0.7 | 2.7 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.7 | 2.6 | GO:0034214 | protein hexamerization(GO:0034214) |
0.6 | 3.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.6 | 1.9 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.6 | 3.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.6 | 1.8 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.6 | 1.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.6 | 2.3 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.6 | 1.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.6 | 1.7 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.5 | 2.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.5 | 1.1 | GO:0046958 | nonassociative learning(GO:0046958) |
0.5 | 1.6 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.5 | 2.7 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.5 | 1.6 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
0.5 | 1.5 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.5 | 6.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.5 | 1.5 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.5 | 2.0 | GO:0090427 | activation of meiosis(GO:0090427) |
0.5 | 2.5 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.5 | 1.4 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.5 | 4.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.5 | 1.4 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.5 | 1.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.5 | 0.9 | GO:1902896 | terminal web assembly(GO:1902896) |
0.5 | 3.2 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.4 | 4.0 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.4 | 1.3 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.4 | 3.5 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.4 | 1.8 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.4 | 1.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.4 | 2.6 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.4 | 2.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.4 | 0.8 | GO:0001964 | startle response(GO:0001964) |
0.4 | 1.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 1.6 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.4 | 1.6 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.4 | 0.8 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.4 | 2.8 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.4 | 1.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.4 | 0.4 | GO:0032898 | neurotrophin production(GO:0032898) |
0.4 | 1.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.4 | 1.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.4 | 0.4 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.4 | 1.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.4 | 1.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.4 | 1.1 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.4 | 1.8 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.4 | 1.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 2.2 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.4 | 1.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.4 | 1.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.4 | 1.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.4 | 1.8 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.4 | 1.1 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.3 | 1.0 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.3 | 6.9 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.3 | 5.8 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.3 | 1.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 1.6 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.3 | 1.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 2.9 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.3 | 1.0 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.3 | 0.6 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.3 | 3.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 1.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.3 | 1.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 0.3 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.3 | 0.3 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.3 | 1.9 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 0.9 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.3 | 1.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 0.9 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.3 | 1.8 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.3 | 0.9 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 2.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.3 | 1.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.3 | 0.8 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.3 | 1.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 0.8 | GO:0015888 | thiamine transport(GO:0015888) |
0.3 | 1.1 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.3 | 0.5 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.3 | 1.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 1.9 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.3 | 0.5 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.3 | 1.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.3 | 0.8 | GO:0021554 | optic nerve development(GO:0021554) |
0.3 | 0.8 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.3 | 0.3 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.3 | 2.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 0.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.3 | 0.3 | GO:0060594 | mammary gland specification(GO:0060594) |
0.3 | 0.5 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.3 | 1.8 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.3 | 0.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 0.5 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.3 | 0.5 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.3 | 2.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.3 | 0.8 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.2 | 0.7 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 1.0 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.2 | 2.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 1.0 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.2 | 1.2 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.2 | 0.5 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.2 | 1.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.7 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.2 | 0.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.2 | 2.2 | GO:0015791 | polyol transport(GO:0015791) |
0.2 | 1.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 0.5 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.2 | 0.5 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 0.5 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.2 | 0.2 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.2 | 1.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 0.7 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.2 | 0.7 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.2 | 0.9 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.2 | 0.9 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 0.2 | GO:0070384 | Harderian gland development(GO:0070384) |
0.2 | 0.9 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.2 | 0.2 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 0.5 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 0.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 0.5 | GO:0043465 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.2 | 0.2 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 0.9 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 0.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 0.4 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.2 | 0.2 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.2 | 0.7 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.2 | 3.0 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.2 | 1.5 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 2.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 0.4 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.2 | 0.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 2.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.2 | 2.6 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.2 | 4.9 | GO:0035640 | exploration behavior(GO:0035640) |
0.2 | 0.6 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.2 | 1.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.2 | 1.9 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.2 | 0.4 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.2 | 0.6 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 0.4 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
0.2 | 0.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.8 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 0.6 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.2 | 1.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.6 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.2 | 0.2 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.2 | 0.2 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.2 | 0.8 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 11.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 3.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.2 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.2 | 1.4 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.2 | 0.6 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.2 | 0.6 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 0.2 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.2 | 0.6 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.2 | 0.4 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.2 | 0.4 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.2 | 0.8 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.2 | 0.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 0.4 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.2 | 0.4 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.2 | 0.4 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.2 | 0.6 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 0.7 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 0.5 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 0.5 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.2 | 0.5 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.2 | 1.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 0.9 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.5 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.2 | 1.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 0.7 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.2 | 0.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 0.5 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 0.5 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 0.3 | GO:0099612 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
0.2 | 0.7 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 0.5 | GO:0051610 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 0.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.2 | 0.7 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
0.2 | 0.7 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.2 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 1.0 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.2 | 0.5 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 0.5 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.2 | 0.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.7 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.2 | 1.8 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.2 | 0.5 | GO:0036394 | amylase secretion(GO:0036394) |
0.2 | 0.5 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.2 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 0.2 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 1.6 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 0.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.5 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.2 | 1.5 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.2 | 1.0 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.2 | 0.5 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.6 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.2 | 1.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 0.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 0.2 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.2 | 0.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 4.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 4.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.8 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.5 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 1.3 | GO:0046541 | saliva secretion(GO:0046541) |
0.2 | 0.5 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.6 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 1.1 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.2 | 0.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.2 | 0.5 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.2 | 0.3 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.2 | 0.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 0.5 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.2 | 0.5 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.2 | 0.5 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 0.8 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.2 | 1.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.5 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.4 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.4 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.6 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.7 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.6 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.3 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.1 | 1.6 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 1.9 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.7 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 1.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.7 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 10.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 2.2 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.1 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.1 | 0.4 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.1 | 0.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 0.6 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.1 | 1.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 1.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.9 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.3 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.1 | 1.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.4 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.6 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.3 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.1 | 0.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 1.0 | GO:0097369 | sodium ion import(GO:0097369) |
0.1 | 0.4 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.3 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.4 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.1 | 0.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.4 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.1 | GO:0003284 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.1 | 0.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.4 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.5 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 1.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 1.2 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.1 | 0.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 1.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.3 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 0.4 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.1 | 0.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.1 | 0.6 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.1 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.4 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.1 | 0.1 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.4 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.4 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.1 | 0.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 1.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 2.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.1 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.1 | 0.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.1 | 0.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.8 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.1 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.3 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.1 | 1.3 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.1 | 0.5 | GO:0042637 | catagen(GO:0042637) |
0.1 | 1.6 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.5 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 2.4 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 0.3 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.7 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 1.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.6 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.1 | 0.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.1 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.9 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.5 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.1 | 0.3 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.5 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.9 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.8 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.5 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.4 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.4 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 1.2 | GO:0060384 | innervation(GO:0060384) |
0.1 | 2.7 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.2 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.4 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.4 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.1 | 0.2 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.1 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 0.1 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 0.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.2 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.1 | 0.3 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.9 | GO:0060914 | heart formation(GO:0060914) |
0.1 | 5.3 | GO:0007612 | learning(GO:0007612) |
0.1 | 0.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.6 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.1 | 0.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.1 | 0.1 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.1 | 0.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.2 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.4 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 1.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.2 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.6 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.8 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 2.5 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 3.9 | GO:0071804 | cellular potassium ion transport(GO:0071804) |
0.1 | 0.3 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.4 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 1.1 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.3 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.1 | 0.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.6 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.2 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 1.0 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.1 | 1.0 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.2 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.1 | 0.6 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.5 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 0.3 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 0.2 | GO:0014878 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.7 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.4 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 0.2 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.1 | 0.2 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 1.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.9 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.2 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 0.2 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 5.0 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.8 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.2 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.1 | 0.2 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.2 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.1 | 0.4 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.2 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.5 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.2 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.8 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.8 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 1.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.4 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.1 | 1.4 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.9 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.3 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 0.1 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.7 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.2 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.1 | 0.1 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 2.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.2 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.4 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.6 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.1 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.1 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.1 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.1 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.1 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.1 | 0.8 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.1 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
0.1 | 0.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.1 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 1.2 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 1.8 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.1 | 0.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.2 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 0.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 0.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.3 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.7 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.5 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.3 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.2 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.1 | 0.4 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.3 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.3 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.1 | GO:0048793 | pronephros development(GO:0048793) |
0.1 | 0.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.1 | 0.2 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.1 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.1 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.1 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.7 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.2 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.1 | 0.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.2 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 1.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.4 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.1 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.1 | 0.2 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.1 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.4 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.2 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.1 | 0.2 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.1 | 0.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.4 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.2 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.3 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.2 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.8 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.4 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.1 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.1 | 0.3 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.1 | GO:0006531 | aspartate metabolic process(GO:0006531) |
0.1 | 0.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.2 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.1 | 0.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.6 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.2 | GO:0045762 | positive regulation of adenylate cyclase activity(GO:0045762) |
0.0 | 0.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 0.1 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.2 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.0 | 0.4 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.0 | 0.2 | GO:0007614 | short-term memory(GO:0007614) |
0.0 | 0.4 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 0.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.5 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.0 | 0.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.0 | 0.1 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.0 | 0.3 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.1 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.0 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.2 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.0 | 0.2 | GO:0031280 | negative regulation of cyclase activity(GO:0031280) |
0.0 | 0.2 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.4 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.1 | GO:0044851 | hair cycle phase(GO:0044851) |
0.0 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.1 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.0 | 0.0 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.0 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.2 | GO:0042711 | maternal behavior(GO:0042711) |
0.0 | 0.1 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.0 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 0.1 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.0 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.0 | 0.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.3 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.1 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.0 | 0.5 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.0 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.3 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.0 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.0 | 0.1 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.0 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.7 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.2 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.2 | GO:0015884 | folic acid transport(GO:0015884) |
0.0 | 0.1 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.0 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.0 | 0.1 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.1 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.9 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.6 | GO:0071472 | cellular response to salt stress(GO:0071472) cellular hyperosmotic salinity response(GO:0071475) |
0.0 | 0.1 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.0 | 0.0 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.0 | 0.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.5 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.0 | 0.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.6 | GO:0048854 | brain morphogenesis(GO:0048854) |
0.0 | 0.1 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.0 | 0.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.5 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.0 | 0.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.0 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.0 | 0.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.1 | GO:0044026 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.0 | 0.2 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.0 | 0.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.0 | 0.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.1 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.0 | 0.4 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.0 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.0 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.3 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.1 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.0 | 0.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.2 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.5 | GO:0042755 | eating behavior(GO:0042755) |
0.0 | 0.2 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.0 | 0.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.0 | 0.1 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.0 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.3 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.0 | 0.1 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.0 | 0.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.0 | 0.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.1 | GO:0060180 | female mating behavior(GO:0060180) |
0.0 | 0.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.0 | 0.3 | GO:0032835 | glomerulus development(GO:0032835) |
0.0 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.0 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.2 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
0.0 | 0.2 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 0.1 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.0 | 0.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.1 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.0 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 0.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.0 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.0 | 0.0 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.0 | 0.0 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.0 | 0.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.2 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.1 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.0 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.0 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.0 | 0.0 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.0 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.0 | 0.0 | GO:0099623 | regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.6 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.2 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.0 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.0 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.0 | 0.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.2 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.0 | 0.0 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.0 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.0 | 0.3 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.0 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.0 | 0.1 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.0 | 0.0 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.0 | GO:0072578 | neurotransmitter-gated ion channel clustering(GO:0072578) |
0.0 | 0.0 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.0 | 0.0 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.0 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.0 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.2 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.1 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.0 | 0.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 1.0 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.1 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.2 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.1 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.0 | 0.1 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.0 | 0.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.0 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.1 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.0 | 0.0 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.0 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.0 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.0 | 0.1 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.3 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.0 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.0 | 0.0 | GO:0044321 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.0 | 0.0 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.0 | 0.1 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.0 | 0.0 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.0 | 0.0 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
0.0 | 0.0 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.0 | 0.1 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.0 | 0.0 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.3 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.4 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.0 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.0 | 0.0 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.0 | 0.1 | GO:0032528 | microvillus organization(GO:0032528) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.0 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.0 | 0.1 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.0 | 0.0 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.0 | 0.0 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 0.2 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.0 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.0 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.0 | 0.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 1.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.0 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.0 | 0.2 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.0 | 0.0 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.0 | 0.1 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.0 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.0 | GO:0070293 | renal absorption(GO:0070293) |
0.0 | 0.0 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.0 | 0.0 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.0 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.2 | GO:0045471 | response to ethanol(GO:0045471) |
0.0 | 0.0 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.0 | GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure(GO:0003071) |
0.0 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.0 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.0 | 0.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.0 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.0 | 0.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.0 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.0 | 0.0 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.0 | 0.0 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.1 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.0 | 0.0 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.0 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.0 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.0 | 0.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.1 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.1 | GO:0015858 | nucleoside transport(GO:0015858) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.9 | 2.6 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.8 | 3.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.7 | 3.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.7 | 9.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.7 | 2.6 | GO:0045298 | tubulin complex(GO:0045298) |
0.6 | 2.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.6 | 1.7 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.5 | 4.9 | GO:0005883 | neurofilament(GO:0005883) |
0.5 | 2.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.5 | 6.8 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.4 | 1.3 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.4 | 5.8 | GO:0031045 | dense core granule(GO:0031045) |
0.4 | 0.4 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.4 | 1.1 | GO:0008091 | spectrin(GO:0008091) |
0.4 | 0.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 0.7 | GO:0043511 | inhibin complex(GO:0043511) |
0.3 | 1.4 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 1.7 | GO:0014704 | intercalated disc(GO:0014704) |
0.3 | 3.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.3 | 1.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 12.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 2.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 2.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 1.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 0.8 | GO:0072534 | perineuronal net(GO:0072534) |
0.3 | 2.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.3 | 1.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 1.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 1.0 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 4.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 3.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 1.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 6.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 1.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.2 | 13.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 0.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 0.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 1.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 1.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 1.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 1.1 | GO:0001652 | granular component(GO:0001652) |
0.2 | 5.3 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 0.5 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 2.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.5 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 1.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 1.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 0.5 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 0.3 | GO:0034705 | potassium channel complex(GO:0034705) |
0.2 | 0.2 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 0.3 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 0.7 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.4 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 19.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 1.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.5 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 3.4 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 4.5 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 2.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 1.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.8 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.1 | 3.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 1.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 1.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.3 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.2 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 1.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.2 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 1.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 2.9 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 11.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.5 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.5 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.7 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 4.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.8 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 3.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.5 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.5 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.5 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.3 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.8 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.4 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 2.7 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 0.7 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 1.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 3.4 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.0 | 2.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 2.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 1.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.0 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.0 | 0.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 2.2 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.3 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.1 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.0 | 0.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.2 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.2 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.1 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 0.1 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 0.9 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.0 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 1.2 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.4 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.2 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.2 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.0 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.4 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 1.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.1 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 70.0 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.2 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.0 | GO:0097427 | microtubule bundle(GO:0097427) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.1 | 3.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.0 | 4.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.0 | 5.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.9 | 3.7 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.9 | 2.6 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.8 | 4.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.8 | 3.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.7 | 3.0 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.7 | 2.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.6 | 2.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.6 | 2.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.6 | 1.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.6 | 4.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.6 | 1.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.5 | 2.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.5 | 1.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.5 | 6.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 2.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 1.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.4 | 1.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.4 | 1.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.4 | 1.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.4 | 1.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.4 | 2.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.4 | 1.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.4 | 1.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.4 | 1.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.4 | 2.6 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.4 | 0.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 1.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.4 | 0.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.3 | 1.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 2.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 1.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.3 | 1.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 1.3 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.3 | 1.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 1.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 0.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 1.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 1.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 2.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.3 | 9.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 2.1 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.3 | 2.5 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.3 | 0.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 1.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 0.8 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 1.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 1.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.3 | 0.5 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.3 | 1.8 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.3 | 0.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 1.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 8.0 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.2 | 1.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 0.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 0.7 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 0.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 3.6 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.2 | 0.7 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 1.5 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 1.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 3.8 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.2 | 0.8 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.2 | 0.6 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.2 | 0.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 2.5 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.2 | 1.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 3.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 5.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 0.8 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 0.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 4.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 1.1 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.2 | 0.9 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 0.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 1.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 4.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 0.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 0.5 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 8.0 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 2.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 0.7 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.2 | 2.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 1.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 0.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 0.7 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.2 | 0.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 1.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 0.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 0.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 0.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 1.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 1.3 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.2 | 0.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 1.6 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 0.9 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 3.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 0.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 0.6 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 0.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 3.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 1.6 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 1.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.4 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.1 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 1.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 3.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.8 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 1.9 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.8 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 1.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 1.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 1.6 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 1.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 1.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.5 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 1.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 2.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.3 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 0.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.9 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 1.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 1.2 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 0.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 1.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 1.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 1.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 1.3 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 2.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.2 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 1.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 2.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.8 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.5 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 1.8 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 1.2 | GO:0052714 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.1 | 0.3 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.3 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 0.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 1.1 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.1 | 0.8 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 2.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 1.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 2.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 1.1 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 2.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 2.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.2 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 0.5 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.3 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 2.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.4 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 2.4 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 1.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.5 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 0.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.2 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 3.3 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 1.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.2 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.6 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 0.2 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.3 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.1 | 1.4 | GO:0016247 | channel regulator activity(GO:0016247) |
0.1 | 1.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 1.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 5.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.2 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 1.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 2.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.7 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 2.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.4 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.9 | GO:0071814 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.0 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.1 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.0 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.0 | 0.8 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 2.3 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.0 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.3 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.0 | 0.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.0 | 0.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.0 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.0 | 0.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.6 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.0 | 0.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.4 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.0 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 0.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.4 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.0 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 5.1 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.6 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 1.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.0 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 1.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 0.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.2 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.0 | 0.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.0 | 0.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 1.6 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.0 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.0 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.0 | 0.0 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.7 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.0 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.0 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.0 | 0.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 1.1 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.3 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.0 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.0 | 0.5 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 0.0 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.0 | 0.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.0 | 0.1 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.1 | GO:0005230 | extracellular ligand-gated ion channel activity(GO:0005230) |
0.0 | 0.2 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.1 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.0 | 0.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.5 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.0 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.0 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.1 | GO:0046977 | TAP binding(GO:0046977) |
0.0 | 0.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 0.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.3 | 1.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 2.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 3.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 1.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 1.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 0.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 0.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 0.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 1.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 2.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 2.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 2.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 2.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 2.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 2.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.9 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 3.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 2.8 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 3.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 0.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 6.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 1.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 1.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 9.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 13.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.7 | 0.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 0.4 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.4 | 1.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.4 | 8.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 7.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 0.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 0.6 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.3 | 3.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 3.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 4.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 0.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 4.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 0.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 10.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 1.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 2.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 5.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 2.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 5.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 2.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 2.5 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.2 | 2.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.2 | 1.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 0.2 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.2 | 1.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 2.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 3.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 4.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 0.8 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.2 | 1.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 1.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 2.7 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.1 | 1.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 3.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.1 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 1.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 2.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 1.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 3.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 3.0 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 3.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 1.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 3.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 3.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 0.8 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 1.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 0.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 0.3 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 5.6 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 2.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 2.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 0.5 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 1.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 0.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.8 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.4 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.2 | REACTOME TRANSMEMBRANE TRANSPORT OF SMALL MOLECULES | Genes involved in Transmembrane transport of small molecules |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.9 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 2.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.4 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.0 | 0.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 1.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.0 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 1.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 3.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.1 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.3 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.0 | 0.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.5 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.0 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 1.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.0 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.6 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |